• About Us
  • Advertise
  • Contact Us
  • DMCA
  • Privacy Policy
  • Follow on Google News
Tuesday, July 15, 2025
  • Login
News Punjab
  • Home
  • Punjab
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
  • Auto
  • Sports
  • Finance/Money
  • Others
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
  • Home
  • Punjab
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
  • Auto
  • Sports
  • Finance/Money
  • Others
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
News Punjab
No Result
View All Result
Home Lifestyle Health & Fitness

First mRNA-based COVID 19 vaccine gets nod for phase II/III trial

by News Punjab Desk
August 25, 2021
in Health & Fitness, National
Reading Time: 2 mins read
A A
0
Share on FacebookShare on Twitter

New Delhi: The fight against the ongoing epidemic of COVID-19 is all set to get stronger. The office of the Drug Controller General of India has approved a proposal of the Pune-based Gennova Biopharmaceuticals Ltd., to go in for phase II / III trial of the country’s first mRNA-based vaccine for COVID-19 called HGCO19.

The company had submitted the interim clinical data of the Phase I study to the Central Drugs Standard Control Organisation (CDSCO), the Government of India’s National Regulatory Authority (NRA). The Vaccine Subject Expert Committee (SEC) reviewed the data and found that the vaccine was safe, tolerable, and immunogenic in the participants of the study.

RELATED POSTS

Tvara Superfood Launches India’s First Daily Seed Cycling Blends for Female Hormonal and Chakra Nourishment

Tvara Superfood Launches India’s First Daily Seed Cycling Blends for Female Hormonal and Chakra Nourishment

May 22, 2025
Healing Little Hearts: Dr. Prashant Bobhate Leads Early CHD Detection

Healing Little Hearts: Dr. Prashant Bobhate Leads Early CHD Detection

May 17, 2025

Consequently, the proposal for Phase II and Phase III study for “A prospective, multicentre, randomized, active-controlled, observer-blind, phase II study seamlessly followed by a phase III study to evaluate the safety, tolerability, and immunogenicity of the candidate HGCO19 (covid-19 vaccine) in healthy subjects” was submitted that has now been approved.

The study will be conducted within India in 10-15 sites in Phase II and 22-27 sites in Phase III. Gennova plans to use the DBT-ICMR clinical trial network sites for this study.

The vaccine development program was partly funded by the Department of Biotechnology (DBT), Govt. of India under Ind CEPI, in June 2020. Later on, the DBT further supported the program under the Mission COVID Suraksha – The Indian COVID-19 Vaccine Development Mission, implemented by BIRAC.

“It is a matter of great pride that Nation’s first mRNA-based vaccine is found to be safe and the Drugs Controller General of India DCG(I) has approved Phase II/III trial. We are confident that this will be an important vaccine for both India and the world. This is an important milestone in our Indigenous Vaccine Development Mission and positions India on the Global Map for Novel Vaccine Development,” said Dr.RenuSwarup, Secretary, DBT, and Chairperson, Biotechnology Industry Research Assistance Council (BIRAC).

Dr. Sanjay Singh, CEO of Gennova Biopharmaceuticals Ltd., said that “After establishing the safety of our mRNA-based COVID-19 vaccine candidate HGCO19 in Phase I clinical trial, Gennova’s focus is to start Phase II/III pivotal clinical trial. In parallel, Gennova is investing in scaling up its manufacturing capacity to cater to the nation’s vaccine requirement”. (India Science Wire)

Tags: CDSCOCentral Drugs Standard Control OrganisationCOVID SurakshaDBTDCG (I)Department of BiotechnologyDrug Controller General of IndiaGennova Biopharmaceuticals Ltd.immunogenicityInd CEPImRNAPunesafetytolerabilityvaccine
ShareTweetShareSendSharePinSend
Previous Post

Ogo Nirupama actress Arkoja Acharyya celebrates Rakshabandhan with renowned singer and producer Sarbajit Ghosh through upcoming calendar photoshoot

Next Post

Government incentive in offing for 75 start-ups in telemedicine, artificial intelligence, and digital health

News Punjab Desk

News Punjab Desk

Related Posts

Tvara Superfood Launches India’s First Daily Seed Cycling Blends for Female Hormonal and Chakra Nourishment

Tvara Superfood Launches India’s First Daily Seed Cycling Blends for Female Hormonal and Chakra Nourishment

by News Punjab Desk
May 22, 2025
0

New Delhi, , May 22, 2025 : In a country where conversations around hormonal health and emotional well-being have long...

Healing Little Hearts: Dr. Prashant Bobhate Leads Early CHD Detection

Healing Little Hearts: Dr. Prashant Bobhate Leads Early CHD Detection

by News Punjab Desk
May 17, 2025
0

Every year, approximately 2,00,000 babies in India are born with congenital heart disease (CHD), yet less than 20% receive timely...

Dr Sunita Dube along with 21 Lakh Doctors Supports Tribunal Health law raised in Parliament by MP

Dr Sunita Dube along with 21 Lakh Doctors Supports Tribunal Health law raised in Parliament by MP

by News Punjab Desk
December 12, 2023
0

New Delhi : 12th December 2023: Renowned Radiologist Dr Sunita Dube, a revolutionary doctor has taken a ground-breaking initiative to...

Health check-up camp on 26/11 Martyrs’ Day with PM Modi’s message; Manoj Kumar Jain extended support

Health check-up camp on 26/11 Martyrs’ Day with PM Modi’s message; Manoj Kumar Jain extended support

by News Punjab Desk
November 27, 2023
0

New Delhi : In observance of the 26/11 Martyrs' Day, a mega health check-up camp was organised today, aligning with...

Narayana Health launches their First Ever Brand Campaign ‘Take Care’

Narayana Health launches their First Ever Brand Campaign ‘Take Care’

by News Punjab Desk
September 30, 2023
0

Narayana Health Group – one of India’s leading healthcare providers, committed to delivering exceptional patient care is thrilled to announce...

Next Post

Government incentive in offing for 75 start-ups in telemedicine, artificial intelligence, and digital health

Niti Vakharia Kharwar from Nits saloon was honoured by One Step Charitable Trust as “Real Heroes of Surat”

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Venugopal Naidu Appeals to Citizens to Join Gau Rashtra Yatra

Venugopal Naidu Appeals to Citizens to Join Gau Rashtra Yatra

July 9, 2025
Dr. Shruti Dutt Shines as Esteemed Panelist at Viksit Bharat Conclave 2047 on 25-26. June in the Parliament, Edinburgh Scotland

Dr. Shruti Dutt Shines as Esteemed Panelist at Viksit Bharat Conclave 2047 on 25-26. June in the Parliament, Edinburgh Scotland

July 7, 2025
Kingston Reinforces Legacy of Performance with Refreshed XS Series External SSD Lineup

Kingston Reinforces Legacy of Performance with Refreshed XS Series External SSD Lineup

June 26, 2025

Categories

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion & Beauty
  • Finance/Money
  • Food
  • Health & Fitness
  • India
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Punjab
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • World
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Privacy Policy
  • Follow on Google News

© 2022 News Punjab

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

© 2022 News Punjab

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In